US EditionPeanut Patch Helps Toddlers Build Tolerance to Deadly Allergy
More than 70% of toddlers treated with the Viaskin Peanut Patch tolerated at least three to four peanut kernels after three years, with no treatment-related anaphylaxis reported.
- On November 6, researchers presented a long-term study at the American College of Allergy, Asthma and Immunology 2025 Annual Scientific Meeting showing the Viaskin Peanut Patch helped toddlers with peanut allergies build tolerance.
- The Viaskin Peanut Patch works by delivering small amounts of peanut protein through the skin as an epicutaneous immunotherapy to train the immune system to tolerate peanut exposure and reduce severe reactions.
- After three years, more than 70% of children originally assigned placebo then switched to patch tolerated at least three to four peanut kernels, with milder reactions in food challenges and no anaphylaxis reported.
- The study showed a strong safety profile, with patch-site skin irritation as the most common side effect that subsided over time among study participants .
- Researchers advise parents of toddlers with peanut allergies not to attempt desensitization at home and to consult a board-certified allergist, as early intervention in young children could change peanut allergy's course.
35 Articles
35 Articles
Phase 3 Trial Shows Peanut Patch Treatment Helps Toddlers Build Tolerance to Deadly Allergy
Toddlers safely built a tolerance to small amounts of peanut proteins thanks to a simple skin patch, which helped prevent the progression of a potentially deadly allergy. More than 70% of these toddlers could tolerate 3 or 4 peanut kernels after a 3-year course of treatment, say American scientists working to commercialize the skin patch. […] The post Phase 3 Trial Shows Peanut Patch Treatment Helps Toddlers Build Tolerance to Deadly Allergy app…
Peanut patch treatment 'helps toddlers build tolerance to deadly allergy' - The Mirror
A huge breakthrough has been made with a treatment that could 'help toddlers build tolerance to a potentially-deadly and common allergy' - but researchers also issued a warning to parents
Peanut patch treatment continues to help toddlers safely build tolerance over three years
New research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) offers encouraging news for parents of young children with peanut allergies. A long-term study found that a peanut patch treatment—epicutaneous immunotherapy—continued to help toddlers safely build tolerance to peanuts over three years.
Coverage Details
Bias Distribution
- 37% of the sources are Center, 37% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
